Skip to main content
. 2020 Feb 12;21:50. doi: 10.1186/s12931-020-1310-9

Table 1.

Subject demographics, lung function, symptom scores, imaging parameters, blood and sputum measurements

Variables Healthy S-COPD NS-COPD (Biomass smoke) NS-COPD (Occupational)a S-COPD Vs. BS-COPD S-COPD Vs. NS-COPD (Occupational) BS-COPD Vs. NS-COPD (Occupational)
Mean ± SD Mean ± SD Mean ± SD Mean ± SD
N 118 79 59 34
Sex (M: F) 53%: 47% 100%: 0% 0%: 100% 100%: 0%
Age (Years) 64.4 ± 7.8 67.2 ± 7.4 62.4 ± 7.3 66.7 ± 8.1 < 0.0001 p = ns 0.010
BMI (kg/m2) 21.9 ± 3.8 19.3 ± 3.4 21.3 ± 4.4 20.0 ± 3.3 0.002 p = ns p = ns
Spirometry
 FEV1 Pre (% Predicted) 99.4 ± 14.7 43.1 ± 17.8 39.9 ± 12.4 41.9 ± 14.4 p = ns p = ns p = ns
 FVC Pre (% Predicted) 102.1 ± 16.8 63.6 ± 20.5 57.9 ± 16.04 62.6 ± 19.2 0.005 0.732 0.032
 Δ Reversibility FEV1 Absolute (mL) 40.0 ± 93 160.0 ± 154.0 160 ± 130 170 ± 190 p = ns p = ns p = ns
 Δ Reversibility FEV1% 2.2 ± 4.9 19.0 ± 19.9 25.6 ± 24.1 19.3 ± 20.6 p = ns p = ns p = ns
 Δ Reversibility FVC Absolute (mL) 0.0 ± 190.0 237.0 ± 312.0 240 ± 230 290 ± 300 p = ns p = ns p = ns
 Δ Reversibility FVC % 0.3 ± 7.4 15.5 ± 22.6 23.2 ± 31.5 18.2 ± 22.2 p = ns p = ns p = ns
 FEV1/FVC Post bronchodilator (%) 80.5 ± 6.1 53.1 ± 10.9 56.4 ± 8.2 52.8 ± 9.9 0.045 p = ns 0.051
 PEF (% Predicted) 89.2 ± 16.0 34.5 ± 15.8 29.8 ± 11.2 34.9 ± 24.3 p = ns p = ns p = ns
 FEF25–75 Pre % Predicted 65.7 ± 24.4 15.3 ± 7.4 12.8 ± 6.9 14.8 ± 7.4 p = ns p = ns p = ns
Plethysmography
 TLC Pre (% Predicted) 84.2 ± 15.9 104.1 ± 23.1 99.8 ± 32.6 103.2 ± 27.3 p = ns p = ns p = ns
 RV Pre (% Predicted) 98.8 ± 26.4 180.8 ± 65.09 176.2 ± 72.1 174.2 ± 59.6 p = ns p = ns p = ns
 IC Pre (% Predicted) 75.2 ± 27.3 49.6 ± 18.7 49.8 ± 23.7 43.7 ± 19.3 p = ns p = ns p = ns
 RV/TLC Pre (% Predicted) 116.8 ± 21.4 171.5 ± 29.7 170.9 ± 39.4 175.7 ± 31.2 p = ns p = ns p = ns
 SGaw Pre (% Predicted) 159.6 ± 78.0 36.2 ± 21.0 24.5 ± 13.6 26.9 ± 16.3 0.010 p = ns p = ns
IOS
 R5 (kPa s L−1) Pre (% Predicted) 148 ± 74.8 231.8 ± 96.4 287.3 ± 100.1 244.2 ± 93.5 0.005 p = ns p = ns
 R20 (kPa s L− 1) Pre (% Predicted) 118.0 ± 50.6 130.1 ± 44.6 158.3 ± 51.2 134.6 ± 47.1 0.012 p = ns p = ns
 R5-R20 (kPa s L− 1) Pre 0.16 ± 0.1 0.36 ± 0.2 0.60 ± 0.3 0.39 ± 0.2 < 0.0001 p = ns 0.003
 X5 Pre (kPa s L− 1) −0.24 ± 0.2 − 0.56 ± 0.3 −0.9 ± 0.4 −0.7 ± 0.3 < 0.0001 p = ns p = ns
 Ax Pre (Hz kPa s L− 1) 1.96 ± 2.0 5.59 ± 3.5 10.3 ± 5.7 7.1 ± 3.7 < 0.0001 p = ns 0.034
 RF Pre (Hz) 22.4 ± 6.9 33.4 ± 7.5 37.2 ± 7.4 38.1 ± 10.0 0.022 0.041 p = ns
Gas Diffusion
 DLCo % Predicted 76.7 ± 17.3 54.2 ± 21.9 54.7 ± 17.3 70.2 ± 27.0 p = ns p = ns p = ns
 DLCO / VA 102.5 ± 17.6 79.9 ± 30.3 83.5 ± 15.9 96.2 ± 32.4 p = ns p = ns p = ns
HRCT
 Normal (%) 4.3% 0% 2.4% 0%
 Airways Disease Predominant (%) 59.6% 60.5% 95.2% 71.4%
 ILD Predominant (%) 34.0% 10.5% 0% 3.6%
 Emphysema Predominant (%) 2.1% 28.9% 1 (2.4%) 25.0%s
 Emphysema Score 19.9 ± 38.9 265 ± 342 39.6 ± 69.9 193.4 ± 313.9 0.001 p = ns 0.006
 ↓attenuation on the expiratory CT Score 164.3 ± 169.7 278.9 ± 237.8 479.5 ± 232.7 422 ± 329.1 0.001 0.024 p = ns
 CAT Score 23.6 ± 7.8 22.0 ± 6.5 25.2 ± 8.8 p = ns p = ns p = ns
 SGRQ Score 63.5 ± 18.5 60.2 ± 18.4 59.7 ± 16.3 p = ns p = ns p = ns
 CRP (mg/L) 2.3 ± 2.9 3.6 ± 4.6 5.2 ± 6.7 4.3 ± 3.9 p = ns p = ns p = ns
 Serum Insulin (μIU/mL) 5.5 ± 3.2 3.7 ± 2.7 8.8 ± 4.7 5.3 ± 5.6 0.008 p = ns p = ns
 Hemoglobin (mg/dL) 12.8 ± 1.2 13.6 ± 2.3 11.9 ± 1.9 13.0 ± 2.0 < 0.0001 p = ns p = ns
 Red cell count (106 cells/μL) 4.3 ± 0.5 4.6 ± 0.6 4.3 ± 0.4 4.6 ± 0.5 0.007 p = ns p = ns
 Packed cell volume (%) 39.6 ± 5.2 41.8 ± 6.4 36.7 ± 5.3 40.1 ± 5.8 < 0.0001 p = ns 0.051
 Mean corpuscular volume (fL) 92.4 ± 11.2 91.4 ± 10.8 84.7 ± 10.8 88.2 ± 9.8 0.004 p = ns p = ns
 Blood eosinophils (%) 4.6 ± 3.9 4.7 ± 4.7 5.3 ± 4.7 4.6 ± 4.43 p = ns p = ns p = ns
 Blood eosinophils (cells/μL) 330.4 ± 319 343.5 ± 408 410.03 ± 403.73 337.5 ± 330.09 p = ns p = ns p = ns
Sputum
 Total cell count per ml 1.38 (0.9 2.9) 6.19 (3.2, 9.3) 4.51 (2.5, 6.9) 3.6 (2.4, 7.4) p = ns p = ns p = ns
 Macrophages per ml 0.33 (0.2, 0.6) 0.87 (0.4, 1.2) 0.72 (0.4, 1.3) 0.60 (0.3, 0.9) p = ns p = ns p = ns
 Neutrophils per ml 0.87 (0.5, 2.8) 5.22 (2.6, 8.3) 2.63 (1.7, 5.9) 2.60 (1.2, 6.7) p = ns p = ns p = ns
 Eosinophils per ml 0.006 (0.0, 0.02) 0.139 (0.04, 0.3) 0.25 (0.04, 0.4) 0.21 (0.1, 0.6) p = ns p = ns p = ns
 Lymphocytes per ml 0.014 (0.0, 0.03) 0.032 (0.02, 0.08) 0.03 (0.01, 0.07) 0.03 (0.01, 0.05) p = ns p = ns p = ns

aOut of the 34 occupational COPD, 25 were farmers, 4 were farmers + hard rock mining/sandblasting exposure and 5 had occupational dust exposures for at least 20 years

FEV1 Forced expiratory volume in 1 s, FVC Forced vital capacity, FEF25–75 Forced expiratory flow between 25 and 75% of FVC, PEF Peak expiratory flow, BD Bronchodilator, p-y Pack-years, h-y hour-years, sRaw specific airway resistance, sGaw specific airway conductance, TLC Total lung capacity, RV Residual volumeM, IOS Impulse oscillometry, R5 Resistance at 5 Hz, X5 Reactance at 5 Hz, AX Area under the reactance curve, Fres Resonant frequency, DLCO Diffusing lung co-efficient for carbon monoxide, KCO Transfer coefficient, SGRQ St. George’s Respiratory Questionnaire, CAT COPD assessment test, hsCRP high sensitivity C-reactive protein

Data are presented as means ± SD